• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Respiratory Distress (2045); Seroma (2069)
Event Date 07/01/2004
Event Type  Injury  
Manufacturer Narrative
This event is from the following literature article: demircin m, doðan r, özkan m, özsoy f, kuzgun e, güvener m.Perigraft seroma complicating the modified blalock-taussig shunts: two consecutive instances with review of literature.Turk j pediatr 2004; 46: 275-278.Date of event reflects date of publication which was july - september 2004.No lot number information was supplied; therefore, no review of the manufacturing paperwork could be performed.The device remained implanted; consequently, a direct product analysis was not possible.
 
Event Description
In the medical literature, an article, "perigraft seroma complicating the modified blalock-taussig shunts: two consecutive instances with review of literature" was reviewed.A single stage surgical repair was planned for a (b)(6) boy with tetralogy of fallot.A left modified b-t shunt was then performed with a 5 mm thin-walled gore-tex® vascular graft configured for pediatric shunts.Early postoperative period was uneventful, and the drainage tube was removed on the second postoperative day.The patient developed respiratory distress on the fifth day.Chest x-ray revealed left superior mediastinal mass.Thoracal computerized tomography (ct) demonstrated perigraft seroma.Re-thoracotomy was performed and the clear and gelatinous seroma material was removed and silicone drainage tube was replaced.The lung fully re-expanded soon after surgery and the patient was kept under controlled ventilation for one day.The composition of the drainage changed to chylous in nature on the third postoperative day and continued for seven more days (200 cc/day).Dietary control and continuous intravenous somatostatin infusion controlled the drainage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TEX® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
sandra whicker
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5567927
MDR Text Key42411712
Report Number2017233-2016-00345
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
K802095
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial
Report Date 03/16/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/11/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age1 YR
-
-